GliaPharm SA
PrivateLast Round
Grant
Dec 14, 2023
Total Funding Raised
$6.46M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GliaPharm SA is a biotechnology company that develops small molecule therapies targeting glial cells to treat neurological and psychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GliaPharm SA Comparables
Compare GliaPharm SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AstronauTx | 86% | |
| Cerecin | 72% | |
| ScandiBio Therapeutics | 70% |
GliaPharm SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 14, 2023 | ||||
| Debt | Jul 4, 2022 | ||||
| Seed | May 25, 2020 | ||||
| Debt | Aug 6, 2018 |
GliaPharm SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Technological Innovation | Debt |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 214% MoM, reaching 2.6K.
- Apr 6, 2026
Monthly visitors grew 131% MoM, reaching 1.3K.
GliaPharm SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GliaPharm SA's valuation, stock price, and market status.
Is GliaPharm SA a public or private company?
GliaPharm SA is a private company.
What is the current stock price of GliaPharm SA?
GliaPharm SA is a private company with no public stock price. No recent secondary market data is available.
How much is GliaPharm SA worth (valuation)?
Valuation information for GliaPharm SA is not publicly available.
Can I buy GliaPharm SA stock?
GliaPharm SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GliaPharm SA's last funding round?
GliaPharm SA's most recent funding round was Grant on December 14, 2023.
Who are the main investors in GliaPharm SA?
Key investors in GliaPharm SA include Foundation for Technological Innovation, Alzheimer's Drug Discovery Foundation.
Will GliaPharm SA IPO soon?
No public IPO plans have been announced for GliaPharm SA.
How can I track GliaPharm SA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GliaPharm SA's secondary market activity and sign up for updates.